Primary Care Providers’ Awareness of Comorbidities and New Advanced Therapies for Atopic Dermatitis: A Cross Sectional Survey From Ontario

Abstract

Keywords

atopic dermatitis awareness family physician biologics JAK inhibitors

Get full access to this article

View all access options for this article.

References

Muir

Falk

. Eosinophilic esophagitis: a review. JAMA. 2021;326(13):1310-1318.doi:10.1001/jama.2021.14920

34609446

Schonmann

Mansfield

KE.

Hayes

et al. Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract. 2020;8(1):248-257.doi:10.1016/j.jaip.2019.08.030

31479767

CH.

Chung

Simpson

. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019;6(12):133.doi:10.3390/children6120133

31810362

Kharaba

Feghali

El Husseini

et al. An assessment of quality of life in patients with asthma through physical, emotional, social, and occupational aspects. A cross-sectional study. Front Public Health. 2022;10:883784.doi:10.3389/fpubh.2022.883784

36117601

Mastorino

Rosset

Gelato

et al. Chronic pruritus in atopic patients treated with Dupilumab: real life response and related parameters in 354 patients. Pharmaceuticals. 2022;15(7):883.doi:10.3390/ph15070883

35890180

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB